Torrent Pharmaceuticals Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2016 - 2020
Revenue	122,481	115,161	107,278	96,202	85,080	80,046	Upgrade
Revenue Growth (YoY)	9.13%	7.35%	11.51%	13.07%	6.29%	0.82%	Upgrade
Cost of Revenue	29,779	27,759	26,862	27,352	24,420	21,464	Upgrade
Gross Profit	92,702	87,402	80,416	68,850	60,660	58,582	Upgrade
Selling, General & Admin	24,098	22,708	20,166	17,052	15,483	14,597	Upgrade
Other Operating Expenses	28,674	27,484	26,573	23,377	20,865	19,184	Upgrade
Operating Expenses	60,821	58,141	54,693	47,449	42,967	40,354	Upgrade
Operating Income	31,881	29,261	25,724	21,400	17,693	18,228	Upgrade
Interest Expense	-2,164	-2,514	-3,526	-3,322	-2,529	-3,508	Upgrade
Interest & Investment Income	201.9	201.9	114.8	147.8	71.5	50.7	Upgrade
Currency Exchange Gain (Loss)	-166.1	-166.1	-39.1	-180.8	1,695	319.7	Upgrade
Other Non Operating Income (Expenses)	-753.1	6.9	314.4	61.1	76	21.7	Upgrade
EBT Excluding Unusual Items	29,000	26,790	22,587	18,106	17,007	15,112	Upgrade
Merger & Restructuring Charges	-130	-	-	-	-4,847	-	Upgrade
Gain (Loss) on Sale of Investments	177.3	167.3	179.9	195.1	101.4	155.8	Upgrade
Gain (Loss) on Sale of Assets	43.4	13.4	-0.2	216.2	-	-	Upgrade
Asset Writedown	-	-	-129.7	-45.6	-2.3	-4.8	Upgrade
Other Unusual Items	-242.1	-242.1	883.8	-	-	-	Upgrade
Pretax Income	28,848	26,728	23,521	18,472	12,259	15,263	Upgrade
Income Tax Expense	7,446	7,616	6,957	6,019	4,487	2,744	Upgrade
Earnings From Continuing Operations	21,403	19,113	16,564	12,452	7,772	12,519	Upgrade
Net Income	21,403	19,113	16,564	12,452	7,772	12,519	Upgrade
Net Income to Common	21,403	19,113	16,564	12,452	7,772	12,519	Upgrade
Net Income Growth	18.75%	15.39%	33.02%	60.22%	-37.92%	22.17%	Upgrade
Shares Outstanding (Basic)	338	338	338	338	338	338	Upgrade
Shares Outstanding (Diluted)	338	338	338	338	338	338	Upgrade
EPS (Basic)	63.23	56.47	48.94	36.79	22.96	36.99	Upgrade
EPS (Diluted)	63.23	56.47	48.94	36.79	22.96	36.99	Upgrade
EPS Growth	18.75%	15.39%	33.02%	60.22%	-37.92%	22.17%	Upgrade
Free Cash Flow	13,582	19,732	28,333	17,942	16,004	16,702	Upgrade
Free Cash Flow Per Share	40.13	58.30	83.72	53.01	47.29	49.35	Upgrade
Dividend Per Share	-	32.000	28.000	22.000	16.500	17.500	Upgrade
Dividend Growth	-	14.29%	27.27%	33.33%	-5.71%	105.88%	Upgrade
Gross Margin	75.69%	75.89%	74.96%	71.57%	71.30%	73.19%	Upgrade
Operating Margin	26.03%	25.41%	23.98%	22.25%	20.80%	22.77%	Upgrade
Profit Margin	17.47%	16.60%	15.44%	12.94%	9.13%	15.64%	Upgrade
Free Cash Flow Margin	11.09%	17.14%	26.41%	18.65%	18.81%	20.87%	Upgrade
EBITDA	39,478	36,758	33,249	28,026	23,823	24,291	Upgrade
EBITDA Margin	32.23%	31.92%	30.99%	29.13%	28.00%	30.35%	Upgrade
D&A For EBITDA	7,598	7,498	7,526	6,626	6,130	6,063	Upgrade
EBIT	31,881	29,261	25,724	21,400	17,693	18,228	Upgrade
EBIT Margin	26.03%	25.41%	23.98%	22.25%	20.80%	22.77%	Upgrade
Effective Tax Rate	25.81%	28.49%	29.58%	32.59%	36.60%	17.98%	Upgrade
Revenue as Reported	121,994	115,394	107,858	96,653	87,046	80,615	Upgrade

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.